Publications by authors named "Sigrun Hallmeyer"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,899

Total Likes

566

Extended Reach

2,384,891

Social Features

327
C
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
Ilana M Braun, Kari Bohlke, Donald I Abrams, Holly Anderson, Lynda G Balneaves, Gil Bar-Sela, Daniel W Bowles, Peter R Chai, Anuja Damani, Arjun Gupta

May 2024

Videos about Article: user user user 1

4 2 88 5 20

View All Article and Social Media Activity
I
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
Brendan D Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries, Lynn Feun, Kim A Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang

J Immunother Cancer· December 2022

Videos about Article: user

1 15

View All Article and Social Media Activity
M
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
Julie R Brahmer, Christina Lacchetti, Bryan J Schneider, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marc S Ernstoff, Jennifer M Gardner, Pamela Ginex

June 2018

Videos about Article: user user

2 2 6 179 4 82

View All Article and Social Media Activity
I
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.
Jeanne Carter, Christina Lacchetti, Barbara L Andersen, Debra L Barton, Sage Bolte, Shari Damast, Michael A Diefenbach, Katherine DuHamel, Judith Florendo, Patricia A Ganz

J Clin Oncol· February 2018

Videos about Article: user user

2 8 34 5

View All Article and Social Media Activity
R
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
John M Kirkwood, Lisa A Kottschade, Robert R McWilliams, Nikhil I Khushalani, Sekwon Jang, Sigrun Hallmeyer

Immunotherapy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing.
Sigrun Hallmeyer, Michael A Thompson, Veronica Fitzpatrick, Yunqi Liao, Michael P Mullane

Biol Methods Protoc· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies.
Michael A Thompson, Sigrun Hallmeyer, Veronica E Fitzpatrick, Yunqi Liao, Michael P Mullane

J Patient Cent Res Rev· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
Andrea Eisen, Mark R Somerfield, Melissa K Accordino, Phillip S Blanchette, Mark J Clemons, Sigrun Hallmeyer

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective, Longitudinal Evaluation of SARS-CoV-2 COVID-19 Exposure, Use of Protective Equipment and Social Distancing in a Group of Community Physicians.
Eli D Ehrenpreis, Sigrun Hallmeyer, David H Kruchko, Alexea A Resner, Nhan Dang

Healthcare (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.
Robert H I Andtbacka, Brendan Curti, Gregory A Daniels, Sigrun Hallmeyer, Eric D Whitman

J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Merve Hasanov, Denái R Milton, William H Sharfman, Bret Taback, Lee D Cranmer, Sigrun Hallmeyer

Oncoimmunology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.
Daniel J Olson, Zeynep Eroglu, Bruce Brockstein, Andrew S Poklepovic, Madhuri Bajaj, Sigrun Hallmeyer

J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E.
Sigrun Hallmeyer, Rene Gonzalez, David H Lawson, Lee D Cranmer, Gerald P Linette

Melanoma Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM.
Joseph I Clark, Michael K K Wong, Howard L Kaufman, Gregory A Daniels, Michael A Morse, Sigrun Hallmeyer

Clin Genitourin Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?
Victoria Shlensky, Sigrun Hallmeyer, Lourdes Juarez, Barbara V Parilla

AJP Rep· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Robert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, Sigrun Hallmeyer, Mohammed Milhem

Head Neck· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing of New and Old Therapies for Metastatic Melanoma.
Megan Ratterman, Sigrun Hallmeyer, Jon Richards

Curr Treat Options Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.
Elizabeth I Buchbinder, Anasuya Gunturi, Jessica Perritt, Janice Dutcher, Sandra Aung, Sigrun Hallmeyer

J Immunother Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study.
Mark R Middleton, Stéphane Dalle, Joel Claveau, Pilar Mut, Sigrun Hallmeyer

Cancer Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma.
Majid Mohiuddin, Harold Park, Sigrun Hallmeyer, Jon Richards

Cureus· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States.
Lawrence Flaherty, Omid Hamid, Gerald Linette, Lynn Schuchter, Sigrun Hallmeyer

Cancer J· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide.
Supriya Perambakam, Sigrun Hallmeyer, Samarth Reddy, Nadim Mahmud, Linda Bressler

Cancer Immunol Immunother· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative tumor board: Recurrent lymphoma.
April Yuning Feng, Sigrun Hallmeyer, David Peace, Jenna Wunder, Sara L Warber

Integr Cancer Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis